BPC-157 10 mg/vial – US Stock

BPC-157 from Hilma Biocare is a synthetic 15-amino-acid peptide supplied as injectable powder. The supplied product information describes BPC-157 as a peptide derived from a gastric protein and discusses its activity in areas including tissue repair, inflammatory signaling, gastrointestinal tissue, and angiogenesis.

The product contains 10 mg of BPC-157 per vial and has a stated active half-life of approximately 7–30 minutes.

Product Overview

BPC-157, also referred to as Body Protecting Compound, is a synthetic peptide consisting of 15 amino acids. The source material describes research involving tissue-related processes, growth-factor signaling, vascular pathways, inflammatory mediators, and cellular protection.

According to the supplied information, BPC-157 is associated with signaling involving growth factors such as TGF-beta and FGF, as well as pathways related to vascular endothelial growth factor (VEGF).

Active Ingredient

BPC-157 is the stated active compound.

Product Form and Strength

This product is supplied as injectable powder, with 10 mg (10,000 mcg) of BPC-157 per vial.

Product Specifications

Product Characteristics

Tissue-Related Research

The supplied product information describes BPC-157 in relation to processes involving muscles, tendons, ligaments, bones, and skin. It also discusses growth-factor signaling associated with cellular proliferation and extracellular matrix formation.

These descriptions reflect the supplied product information and should not be interpreted as established clinical treatment claims.

Gastrointestinal Research

BPC-157 is described in the source material in connection with gastric and gastrointestinal tissue, including research concerning mucosal integrity and inflammatory conditions.

Angiogenesis and Vascular Signaling

The supplied information discusses BPC-157’s relationship with angiogenesis and VEGF-associated pathways. Angiogenesis refers to the formation of new blood vessels, and this mechanism is relevant to research into tissue vascularization and repair.

Inflammatory and Cellular Pathways

The source describes BPC-157 in relation to inflammatory mediators including TNF-alpha and IL-6. It also discusses cellular responses involving apoptosis and oxidative stress.

Because the supplied information does not establish approved clinical indications for these properties, they are presented here as product-source descriptions rather than guaranteed therapeutic effects.

Research Areas Described in the Source

The supplied material identifies several areas of interest for BPC-157 research:

• Tissue regeneration
• Connective tissue and musculoskeletal research
• Gastrointestinal tissue
• Inflammatory signaling
• Angiogenesis
• Growth-factor pathways
• Cellular protection

The source also describes research involving liver, pancreatic, and cardiac tissue.

Administration Information

The source material contains specific injection routes, locations, dosing ranges, and course durations. Because BPC-157 is a pharmacologically active peptide and these details could constitute actionable medical-use instructions, they are not reproduced as administration or dosing recommendations here.

Anyone considering use of an injectable peptide should obtain appropriate guidance from a qualified healthcare professional.

Drug Interactions and Precautions

The supplied information advises consultation with a physician before use when taking medications for cardiovascular or neurological conditions or when there is a history of cancer.

The source also describes reported reactions including injection-site pain or swelling, joint discomfort, anxiety, panic attacks, changes in heart rate, insomnia or drowsiness, weakness, fatigue, appetite changes, depression, and anhedonia.

These reported effects should not be interpreted as a complete safety profile. Medical evaluation is appropriate before using an investigational or medically relevant peptide.

About Hilma Biocare USA

BPC-157 10 mg/vial is part of the Hilma Biocare product range. This presentation contains 10 mg of BPC-157 in one vial and is supplied as injectable powder, listed as US Stock.

Important Information

BPC-157 is a biologically active peptide, and the information provided on this page is intended for product identification and general informational purposes. It does not constitute personalized medical advice or establish BPC-157 as an approved treatment or cure for any disease or injury.

No individualized dosing, injection instructions, treatment protocols, or recommendations for combining BPC-157 with other compounds are provided.